世界のクロストリジウム・ディフィシル感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Clostridium Difficile Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1388
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、クロストリジウム・ディフィシル感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射可能）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン販売）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・クロストリジウム・ディフィシル感染症治療の市場動向
・企業の競争状況、市場シェア
・クロストリジウム・ディフィシル感染症治療の種類別市場規模（経口、注射可能）
・クロストリジウム・ディフィシル感染症治療の用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン販売）
・クロストリジウム・ディフィシル感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・クロストリジウム・ディフィシル感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・クロストリジウム・ディフィシル感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・クロストリジウム・ディフィシル感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・クロストリジウム・ディフィシル感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、Baxter International、Sanofi、Pfizer、Novartis、Astellas Pharma、Eli Lilly、AstraZeneca、Actelion Pharmaceuticals、Mylan）
・結論

Clostridium difficile is one of the most common hospital acquired infections and in the last decade, there has been a notable increase in the incidence of clostridium difficile infection as well as the severity of the infection owing to recurrence and antibiotic resistance. Disproportionately higher incidence is seen in patients undergoing a long-term antibiotic treatment such as in patients with diseases like COPD and urinary tract infection. A rising prevalence of these diseases would subsequently accelerate the growth of the global clostridium difficile infection treatment market.
Clostridium difficile infection treatment usually occurs when people have taken antibiotics for a long period of time that change the normal colon bacteria allowing the clostridium difficile bacteria to grow and produce its toxins. High CDI risk antibiotics are clindamycin, cephalosporins, and quinolones including ciprofloxacin and levofloxacin. Increasing use of these antibiotics and antimicrobials is driving the incidence of clostridium difficile infection and is likely to drive the global clostridium difficile infection treatment market over the forecast period.

Market Analysis and Insights: Global Clostridium Difficile Infection Treatment Market
The global Clostridium Difficile Infection Treatment market size is projected to reach US$ 1040 million by 2026, from US$ 698.6 million in 2019, at a CAGR of 5.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clostridium Difficile Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clostridium Difficile Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clostridium Difficile Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clostridium Difficile Infection Treatment market.

Global Clostridium Difficile Infection Treatment Scope and Market Size
Clostridium Difficile Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clostridium Difficile Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Injectable

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Baxter International
Sanofi
Pfizer
Novartis
Astellas Pharma
Eli Lilly
AstraZeneca
Actelion Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clostridium Difficile Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Clostridium Difficile Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Sales
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Clostridium Difficile Infection Treatment Market Perspective (2016-2027)
2.2 Clostridium Difficile Infection Treatment Growth Trends by Regions
2.2.1 Clostridium Difficile Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clostridium Difficile Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Clostridium Difficile Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Clostridium Difficile Infection Treatment Industry Dynamic
2.3.1 Clostridium Difficile Infection Treatment Market Trends
2.3.2 Clostridium Difficile Infection Treatment Market Drivers
2.3.3 Clostridium Difficile Infection Treatment Market Challenges
2.3.4 Clostridium Difficile Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Clostridium Difficile Infection Treatment Players by Revenue
3.1.1 Global Top Clostridium Difficile Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Clostridium Difficile Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Clostridium Difficile Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clostridium Difficile Infection Treatment Revenue
3.4 Global Clostridium Difficile Infection Treatment Market Concentration Ratio
3.4.1 Global Clostridium Difficile Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clostridium Difficile Infection Treatment Revenue in 2020
3.5 Clostridium Difficile Infection Treatment Key Players Head office and Area Served
3.6 Key Players Clostridium Difficile Infection Treatment Product Solution and Service
3.7 Date of Enter into Clostridium Difficile Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Clostridium Difficile Infection Treatment Breakdown Data by Type
4.1 Global Clostridium Difficile Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Clostridium Difficile Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Clostridium Difficile Infection Treatment Breakdown Data by Application
5.1 Global Clostridium Difficile Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Clostridium Difficile Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Clostridium Difficile Infection Treatment Market Size (2016-2027)
6.2 North America Clostridium Difficile Infection Treatment Market Size by Type
6.2.1 North America Clostridium Difficile Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Clostridium Difficile Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Clostridium Difficile Infection Treatment Market Size by Type (2016-2027)
6.3 North America Clostridium Difficile Infection Treatment Market Size by Application
6.3.1 North America Clostridium Difficile Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Clostridium Difficile Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Clostridium Difficile Infection Treatment Market Size by Application (2016-2027)
6.4 North America Clostridium Difficile Infection Treatment Market Size by Country
6.4.1 North America Clostridium Difficile Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Clostridium Difficile Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Clostridium Difficile Infection Treatment Market Size (2016-2027)
7.2 Europe Clostridium Difficile Infection Treatment Market Size by Type
7.2.1 Europe Clostridium Difficile Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Clostridium Difficile Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Clostridium Difficile Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Clostridium Difficile Infection Treatment Market Size by Application
7.3.1 Europe Clostridium Difficile Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Clostridium Difficile Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Clostridium Difficile Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Clostridium Difficile Infection Treatment Market Size by Country
7.4.1 Europe Clostridium Difficile Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Clostridium Difficile Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Clostridium Difficile Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Clostridium Difficile Infection Treatment Market Size (2016-2027)
9.2 Latin America Clostridium Difficile Infection Treatment Market Size by Type
9.2.1 Latin America Clostridium Difficile Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Clostridium Difficile Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Clostridium Difficile Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Clostridium Difficile Infection Treatment Market Size by Application
9.3.1 Latin America Clostridium Difficile Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Clostridium Difficile Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Clostridium Difficile Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Clostridium Difficile Infection Treatment Market Size by Country
9.4.1 Latin America Clostridium Difficile Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Clostridium Difficile Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Clostridium Difficile Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Clostridium Difficile Infection Treatment Introduction
11.1.4 Merck Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Clostridium Difficile Infection Treatment Introduction
11.2.4 Baxter International Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.2.5 Baxter International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Clostridium Difficile Infection Treatment Introduction
11.3.4 Sanofi Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Clostridium Difficile Infection Treatment Introduction
11.4.4 Pfizer Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Clostridium Difficile Infection Treatment Introduction
11.5.4 Novartis Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Clostridium Difficile Infection Treatment Introduction
11.6.4 Astellas Pharma Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Clostridium Difficile Infection Treatment Introduction
11.7.4 Eli Lilly Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.7.5 Eli Lilly Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Clostridium Difficile Infection Treatment Introduction
11.8.4 AstraZeneca Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Company Details
11.9.2 Actelion Pharmaceuticals Business Overview
11.9.3 Actelion Pharmaceuticals Clostridium Difficile Infection Treatment Introduction
11.9.4 Actelion Pharmaceuticals Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.9.5 Actelion Pharmaceuticals Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Clostridium Difficile Infection Treatment Introduction
11.10.4 Mylan Revenue in Clostridium Difficile Infection Treatment Business (2016-2021)
11.10.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Clostridium Difficile Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Clostridium Difficile Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Clostridium Difficile Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Clostridium Difficile Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Clostridium Difficile Infection Treatment Market Share by Regions (2016-2021)
Table 8. Global Clostridium Difficile Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Clostridium Difficile Infection Treatment Market Share by Regions (2022-2027)
Table 10. Clostridium Difficile Infection Treatment Market Trends
Table 11. Clostridium Difficile Infection Treatment Market Drivers
Table 12. Clostridium Difficile Infection Treatment Market Challenges
Table 13. Clostridium Difficile Infection Treatment Market Restraints
Table 14. Global Clostridium Difficile Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Clostridium Difficile Infection Treatment Market Share by Players (2016-2021)
Table 16. Global Top Clostridium Difficile Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Infection Treatment as of 2020)
Table 17. Ranking of Global Top Clostridium Difficile Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Clostridium Difficile Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Clostridium Difficile Infection Treatment Product Solution and Service
Table 21. Date of Enter into Clostridium Difficile Infection Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Clostridium Difficile Infection Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Clostridium Difficile Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Clostridium Difficile Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Clostridium Difficile Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Clostridium Difficile Infection Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Clostridium Difficile Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Clostridium Difficile Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Clostridium Difficile Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Clostridium Difficile Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Clostridium Difficile Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Clostridium Difficile Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Clostridium Difficile Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Clostridium Difficile Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Clostridium Difficile Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Clostridium Difficile Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Clostridium Difficile Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Clostridium Difficile Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Clostridium Difficile Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Clostridium Difficile Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Clostridium Difficile Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Clostridium Difficile Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Clostridium Difficile Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Clostridium Difficile Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Clostridium Difficile Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Clostridium Difficile Infection Treatment Product
Table 64. Merck Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Baxter International Company Details
Table 67. Baxter International Business Overview
Table 68. Baxter International Clostridium Difficile Infection Treatment Product
Table 69. Baxter International Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 70. Baxter International Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Clostridium Difficile Infection Treatment Product
Table 74. Sanofi Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Clostridium Difficile Infection Treatment Product
Table 79. Pfizer Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Clostridium Difficile Infection Treatment Product
Table 84. Novartis Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Astellas Pharma Company Details
Table 87. Astellas Pharma Business Overview
Table 88. Astellas Pharma Clostridium Difficile Infection Treatment Product
Table 89. Astellas Pharma Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 90. Astellas Pharma Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Clostridium Difficile Infection Treatment Product
Table 94. Eli Lilly Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Actelion Pharmaceuticals Company Details
Table 101. Actelion Pharmaceuticals Business Overview
Table 102. Actelion Pharmaceuticals Clostridium Difficile Infection Treatment Product
Table 103. Actelion Pharmaceuticals Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 104. Actelion Pharmaceuticals Recent Development
Table 105. Mylan Company Details
Table 106. Mylan Business Overview
Table 107. Mylan Clostridium Difficile Infection Treatment Product
Table 108. Mylan Revenue in Clostridium Difficile Infection Treatment Business (2016-2021) & (US$ Million)
Table 109. Mylan Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clostridium Difficile Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injectable Features
Figure 4. Global Clostridium Difficile Infection Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Online Sales Case Studies
Figure 9. Clostridium Difficile Infection Treatment Report Years Considered
Figure 10. Global Clostridium Difficile Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Clostridium Difficile Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Clostridium Difficile Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Clostridium Difficile Infection Treatment Market Share by Regions (2022-2027)
Figure 14. Global Clostridium Difficile Infection Treatment Market Share by Players in 2020
Figure 15. Global Top Clostridium Difficile Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Infection Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Clostridium Difficile Infection Treatment Revenue in 2020
Figure 17. Global Clostridium Difficile Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Clostridium Difficile Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Clostridium Difficile Infection Treatment Market Share by Type (2016-2027)
Figure 21. North America Clostridium Difficile Infection Treatment Market Share by Application (2016-2027)
Figure 22. North America Clostridium Difficile Infection Treatment Market Share by Country (2016-2027)
Figure 23. United States Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Clostridium Difficile Infection Treatment Market Share by Type (2016-2027)
Figure 27. Europe Clostridium Difficile Infection Treatment Market Share by Application (2016-2027)
Figure 28. Europe Clostridium Difficile Infection Treatment Market Share by Country (2016-2027)
Figure 29. Germany Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Clostridium Difficile Infection Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Clostridium Difficile Infection Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Clostridium Difficile Infection Treatment Market Share by Region (2016-2027)
Figure 39. China Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Clostridium Difficile Infection Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Clostridium Difficile Infection Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Clostridium Difficile Infection Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Clostridium Difficile Infection Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Clostridium Difficile Infection Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Clostridium Difficile Infection Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Clostridium Difficile Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 59. Baxter International Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 66. Actelion Pharmaceuticals Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 67. Mylan Revenue Growth Rate in Clostridium Difficile Infection Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Clostridium Difficile Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1389 2021年4月 125Pages
QYResearch社発行の本調査資料では、クロストリジウム・ディフィシル治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（狭域スペクトル抗生物質、広域スペクトル抗生物質）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米...

世界のクロストリジウム・ディフィシル治療市場 2021：企業別、地域別、種類・用途別

Global Clostridium Difficile Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z03270 2021年4月 124Pages
当調査資料では、クロストリジウム・ディフィシル治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。クロストリジウム・ディフィシル治療の種類別市場規模（狭域スペクトル抗生物質、広域スペクトル抗生物質）、用途別市場規模（病院、診療所、その他）、地域別市場規...

世界の尿路感染症治療市場規模・現状・予測（2021年-2027年）

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5835 2021年4月 98Pages
QYResearch社発行の本調査資料では、尿路感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（複雑UTI、再発性複雑UTI、単純UTI、神経因性膀胱感染症、その他）、用途別市場規模（病院薬局、婦人科及び泌尿器科クリニック、ドラッグス...

世界のクロストリジウム診断市場規模・現状・予測（2021年-2027年）

Global Clostridium Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z1387 2021年4月 127Pages
QYResearch社発行の本調査資料では、クロストリジウム診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロストリジウム・ディフィシル、ウェルシュ菌、ボツリヌス菌、破傷風菌、ソルデリジウム）、用途別市場規模（病院、独立研究所、クリニック...

世界の耳感染症治療市場規模・現状・予測（2021年-2027年）

Global Ear Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2028 2021年4月 90Pages
QYResearch社発行の本調査資料では、耳感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、治療薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界の下気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Lower Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3477 2021年4月 98Pages
QYResearch社発行の本調査資料では、下気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（支持療法、ホスピタルケア、医薬品、ワクチン）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、...

世界の帯状疱疹感染症治療市場規模・現状・予測（2021年-2027年）

Global Herpes Zoster Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2813 2021年4月 98Pages
QYResearch社発行の本調査資料では、帯状疱疹感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、局所、非経口）、用途別市場規模（クリニック、病院、診断センター、在宅ケア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の全身感染症治療市場規模・現状・予測（2021年-2027年）

Global Systemic Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5539 2021年4月 99Pages
QYResearch社発行の本調査資料では、全身感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗ウイルス、防カビ）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

Global Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5010 2021年4月 93Pages
QYResearch社発行の本調査資料では、気道感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬、咳止め薬、鼻充血緩和剤、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、...

世界の気道感染症治療市場規模・現状・予測（2021年-2027年）

世界のクロストリジウム・ディフィシル治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Clostridium Difficile Treatment Market The global Clostridium Difficile Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界のクロストリジウム・ディフィシル治療市場 2021：企業別、地域別、種類・用途別 The Clostridium Difficile Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
世界の院内感染症治療市場規模・現状・予測（2021年-2027年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 21430 million b…
世界の単純ヘルペスウイルス感染症治療市場規模・現状・予測（2021年-2027年） Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blis…